The global FemTech market size is estimated to be valued at USD 25.11 Billion in 2025. It is anticipated to reach a valuation of USD 70.11 Billion by 2032. It is expected to exhibit a CAGR of 15.8% during the forecast period (2025-2032).
FemTech stands for female technology and refers to companies led by women that aim to solve problems affecting women. Increasing focus on preventive healthcare and the spotlight on women’s health issues are anticipated to drive the market growth. This is fueled by technological advances in smartwatches and fitness trackers, which enable the accurate tracking of metrics.
However, the collection of personal health data by FemTech applications and concerns over user privacy can be a challenge for the market.
Key Market Insights
The FemTech market is shaped by investments in women-led startups and the shift towards gender equality.
The full report is now available for purchase: https://www.coherentmi.com/industry-reports/femtech-market
FemTech Market Report Coverage
|
Report Coverage |
Details |
|
Market Revenue in 2025 |
USD 25.11 Billion |
|
Estimated Value by 2032 |
USD 70.11 Billion |
|
Growth Rate |
15.8% |
|
Historical Data |
2020–2024 |
|
Forecast Period |
2025–2032 |
|
Forecast Units |
Value (USD Billion) |
|
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
|
Segments Covered |
|
|
Geographies Covered |
North America (U.S. and Canada), Latin America (Brazil, Argentina, Mexico, and Rest of Latin America), Europe (Italy, Spain, U.K., Germany, France, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific), Middle East (GCC Countries, Israel, and Rest of Middle East), and Africa (South Africa, North Africa, and Central Africa) |
|
Growth Drivers |
|
|
Opportunities |
|
|
Trends |
|
|
Restraints & Challenges |
|
Market Dynamics
Strong demand for female intimate wellness products and solutions is expected to drive the FemTech market growth. The huge stigma surrounding sexual health and lack of representation of women in leadership positions have culminated in the lack of much-needed products. However, government sponsorships for FemTech companies can support the market. This is illustrated by the recent funding given by the U.K. National Institute for Health and Care Research to Calla Lilly Clinical Care, a U.K. startup, on April 03, 2025. The capital will be used in addressing the issue of threatened miscarriage among women.
The misogyny faced by FemTech companies has led to the censorship of digital Ads on major online platforms such as Google and Meta. This has culminated in the launch of campaigns aimed at making female health issues visible and providing wellness products with visible shelf space in retail stores.
The funding challenge faced by women founders has led to the launch of Femtech specific funds. Femtech France launched the Financing Alliance in 2025 for funding women-led startups about USD 2.69 million in 2026. The purpose of developing solutions catering to women’s mental health, chronic conditions, and fertility can augur favorably for the FemTech market.
Market Opportunity: Focus on Maternal and Prenatal Care
The expansion of maternal and prenatal care technologies is likely to provide a viable growth opportunity for the market. As per the World Health Organization, 700 women died from preventable causes in pregnancy daily in 2023. This vital gap presents an opportunity for FemTech firms to provide solutions in tackling pregnancy-related issues. The use of mobile-based prenatal apps for tracking health parameters is a pivotal step in protecting expectant mothers.
Market Challenge: Bias Against Women Founders
The bias against women founders is a major challenge faced by the FemTech market. A prime example is the arrest and sentencing of Mr. Charlie Javice, the founder of student financial aid, Frank, on October 02, 2025. This common trend in all countries prevents actual women founders in raising adequate funding. According to a 2025 report by the Founders Forum Group, only 2.3% of female-founded companies managed to raise capital from venture capital firms. This underrepresentation of female leadership can be detrimental to the market if not corrected immediately.
Analyst’s View
Recent Developments
Midi Health, a U.S. startup focused on solutions for perimenopause and menopause, raised USD 50 million in Series C funding on October 03, 2025.
Competitor Insights
Market Segmentation
Regional Insights
Related Reports :